Lovastatin sensitized human glioblastoma cells to TRAIL-induced apoptosis
Open Access
- 11 October 2007
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 86 (3) , 273-283
- https://doi.org/10.1007/s11060-007-9475-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted AgentsThe Oncologist, 2006
- Differential role of hydrogen peroxide and staurosporine in induction of cell death in glioblastoma cells lacking DNA-dependent protein kinaseApoptosis, 2005
- Death to the bad guys: Targeting cancer via Apo2L/TRAILApoptosis, 2005
- Glioblastoma cells deficient in DNA‐dependent protein kinase are resistant to cell deathJournal of Cellular Physiology, 2004
- Lovastatin‐induced up‐regulation of the BH3‐only protein, Bim, and cell death in glioblastoma cellsJournal of Neurochemistry, 2004
- Caspase‐8 levels affect necessity for mitochondrial amplification in death ligand‐induced glioma cell apoptosisMolecular Carcinogenesis, 2004
- Mechanisms of ApoptosisThe American Journal of Pathology, 2000
- The Hallmarks of CancerCell, 2000
- Regulation of the mevalonate pathwayNature, 1990
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988